Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty
CSP #571 - Drug-eluting Stents vs. Bare Metal Stents in Saphenous Vein Graft Angioplasty (DIVA)
Status: Enrolling
Updated:  12/31/1969
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
mi
from
Saint Louis, MO
Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty
CSP #571 - Drug-eluting Stents vs. Bare Metal Stents in Saphenous Vein Graft Angioplasty (DIVA)
Status: Enrolling
Updated: 12/31/1969
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study of Exercise Training in Hypertrophic Cardiomyopathy
A Randomized Trial of Moderate Intensity Exercise Training in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Stanford, CA
Study of Exercise Training in Hypertrophic Cardiomyopathy
A Randomized Trial of Moderate Intensity Exercise Training in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Study of Exercise Training in Hypertrophic Cardiomyopathy
A Randomized Trial of Moderate Intensity Exercise Training in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated:  12/31/1969
University of Michigan Cardiovascular Center
mi
from
Ann Arbor, MI
Study of Exercise Training in Hypertrophic Cardiomyopathy
A Randomized Trial of Moderate Intensity Exercise Training in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 12/31/1969
University of Michigan Cardiovascular Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Clinically Indicated Magnetic Resonance Imaging in Patients With Cardiac Devices
Clinically Indicated Magnetic Resonance Imaging of Patients With Permanent Pacemakers (PPM) and Implantable Defibrillators (ICD)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital, Blalcok 5 MRI
mi
from
Baltimore, MD
Clinically Indicated Magnetic Resonance Imaging in Patients With Cardiac Devices
Clinically Indicated Magnetic Resonance Imaging of Patients With Permanent Pacemakers (PPM) and Implantable Defibrillators (ICD)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital, Blalcok 5 MRI
mi
from
Baltimore, MD
Click here to add this to my saved trials
Nurse-Led Heart Failure Care Transition Intervention for African Americans: The Navigator Program
Nurse-Led Heart Failure Care Transition Intervention for African Americans
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Nurse-Led Heart Failure Care Transition Intervention for African Americans: The Navigator Program
Nurse-Led Heart Failure Care Transition Intervention for African Americans
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Cooper University Hospital
mi
from
Camden, NJ
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Harborview Medical Center
mi
from
Seattle, WA
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
The Indiana Heart Hospital
mi
from
Indianapolis, IN
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
The Indiana Heart Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Inova Fairfax Hospital
mi
from
Falls Church, VA
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente
mi
from
San Francisco, CA
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente
mi
from
San Francisco, CA
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Methodist Hospital of Indiana
mi
from
Indianapolis, IN
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Methodist Hospital of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
New York University Hospital
mi
from
New York, NY
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
New York University Hospital
mi
from
New York, NY
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Tennessee Baptist Memorial Hospital
mi
from
Memphis, TN
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Tennessee Baptist Memorial Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
University of South Florida
mi
from
Tampa, FL
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Hannover Medical School
mi
from
Hannover,
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Hannover Medical School
mi
from
Hannover,
Click here to add this to my saved trials
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated:  12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Miami Healthy Heart Initiative a Behavioral Study on Cardiovascular Risk Factors
Miami Healthy Heart Initiative (MHHI) a Randomized Study of Behavioral Risk Factors for Cardiovascular Disease in Latino and Hispanic Patients With Poorly Controlled Diabetes
Status: Enrolling
Updated:  12/31/1969
University of Miami
mi
from
Miami, FL
Miami Healthy Heart Initiative a Behavioral Study on Cardiovascular Risk Factors
Miami Healthy Heart Initiative (MHHI) a Randomized Study of Behavioral Risk Factors for Cardiovascular Disease in Latino and Hispanic Patients With Poorly Controlled Diabetes
Status: Enrolling
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Sex Hormones and Orthostatic Tolerance
Sex Hormones and Orthostatic Tolerance
Status: Enrolling
Updated:  12/31/1969
John B. Pierce Laboratory
mi
from
New Haven, CT
Sex Hormones and Orthostatic Tolerance
Sex Hormones and Orthostatic Tolerance
Status: Enrolling
Updated: 12/31/1969
John B. Pierce Laboratory
mi
from
New Haven, CT
Click here to add this to my saved trials
Topical Radial Artery Vasodilation
The Effect of Topical Administration of Lidocaine/Nitroglycerin Combination Versus Placebo on Radial Artery Access in Patients Undergoing Cardiac Catheterization Via the Radial Artery
Status: Enrolling
Updated:  12/31/1969
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Topical Radial Artery Vasodilation
The Effect of Topical Administration of Lidocaine/Nitroglycerin Combination Versus Placebo on Radial Artery Access in Patients Undergoing Cardiac Catheterization Via the Radial Artery
Status: Enrolling
Updated: 12/31/1969
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Care Guides in the Primary Care Office (Phase II)
Care Guides: Can Trained Laypersons Help Manage Chronic Disease? A Randomized Trial.
Status: Enrolling
Updated:  12/31/1969
Allina Hospitals and Clinics
mi
from
Minneapolis, MN
Care Guides in the Primary Care Office (Phase II)
Care Guides: Can Trained Laypersons Help Manage Chronic Disease? A Randomized Trial.
Status: Enrolling
Updated: 12/31/1969
Allina Hospitals and Clinics
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)
A Randomized Study to Assess the Effect and Safety Profile of Thymoglobulin® for the Prevention of Cardiac Allograft Vasculopathy in Primary Cardiac Transplant Recipients: A 12-month, Single Center, Randomized, Open-label Study of Efficacy Comparing Immediate Treatment With and Without Thymoglobulin® 1.5 mg/kg/d for 5 Consecutive Days in Heart Transplant Recipients.
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Beverly Hills, CA
A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)
A Randomized Study to Assess the Effect and Safety Profile of Thymoglobulin® for the Prevention of Cardiac Allograft Vasculopathy in Primary Cardiac Transplant Recipients: A 12-month, Single Center, Randomized, Open-label Study of Efficacy Comparing Immediate Treatment With and Without Thymoglobulin® 1.5 mg/kg/d for 5 Consecutive Days in Heart Transplant Recipients.
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Noninvasive Imaging of Heart Failure: A Pilot Study
Noninvasive Imaging of Heart Failure
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Noninvasive Imaging of Heart Failure: A Pilot Study
Noninvasive Imaging of Heart Failure
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
The Emory Clinic
mi
from
Atlanta, GA
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
The Emory Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
University of Chicago
mi
from
Chicago, IL
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
Saint Vincent Health
mi
from
Indianapolis, IN
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
Saint Vincent Health
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
Newark Beth Israel Medical Center
mi
from
Newark, NJ
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
Innova Heart and Vascular Institute Research - Cardiac Vascular & Thoracic Surgery Associates, PC
mi
from
Falls Church, VA
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
Innova Heart and Vascular Institute Research - Cardiac Vascular & Thoracic Surgery Associates, PC
mi
from
Falls Church, VA
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
Northwest Cardiothoracic &Transplant Surgeons
mi
from
Spokane, WA
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
Northwest Cardiothoracic &Transplant Surgeons
mi
from
Spokane, WA
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Hospital - Phoenix
mi
from
Phoenix, AZ
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Hospital - Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
University of Southern California
mi
from
Los Angeles, CA
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
Sharp Memorial
mi
from
San Diego, CA
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
Sharp Memorial
mi
from
San Diego, CA
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital - Leprino
mi
from
Aurora, CO
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial
A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital - Leprino
mi
from
Aurora, CO
Click here to add this to my saved trials